ArticleACS omega2026
Histamine Adsorption on Pristine and Doped Graphene for Biosensing: A First-Principles Study.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Histamine is a key immune regulator involved in allergic and inflammatory responses and is implicated in a range of immune dysregulation disorders. Reliable, continuous detection of histamine remains challenging due to its low concentrations and dynamic levels of release. In this investigation, the interaction of histamine with pristine and doped graphene monolayers, including oxygen-, boron nitride-, and silicon-doped graphene, was examined as a basis for potential biosensor materials. Density functional theory (DFT) calculations were performed to evaluate adsorption energies, defect formation energies, charge transfer, band structures, and recovery times. The results reveal that pristine graphene exhibits a weak interaction with histamine and a negligible electronic response. Silicon-doped graphene shows high sensitivity but exhibits excessively long recovery times. In contrast, graphene oxide with an oxygen concentration of 6.25% and boron nitride-doped graphene with a concentration of 12.5% display moderate adsorption energies, short recovery times, and favorable electronic responses. Notably, graphene oxide with a concentration of 6.25% exhibits band gap closure at the Fermi level following histamine adsorption. These results indicate that oxygen- and boron nitride-doped graphene monolayers with concentrations of 6.25% and 12.5%, respectively, are promising materials for histamine-sensing applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.